-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Morgan Stanley Maintains Equal-Weight on Nevro, Lowers Price Target to $46

Benzinga · 01/06/2023 10:04
Morgan Stanley analyst Cecilia Furlong maintains Nevro (NYSE:NVRO) with a Equal-Weight and lowers the price target from $49 to $46.